Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer’s disease

Lewis K. Penny, Richard Lofthouse, Mohammad Arastoo, Andy Porter, Soumya Palliyil, Charles R. Harrington, Claude M. Wischik

PDF(1146 KB)

Translational Neurodegeneration ›› 2024, Vol. 13 ›› Issue (0) : 25. DOI: 10.1186/s40035-024-00417-w

REVIEW

Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer’s disease

Author information +

History +

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 13(0): 25 https://doi.org/10.1186/s40035-024-00417-w

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

PDF(1146 KB)

Accesses

Citation

Detail

Sections

Recommended